Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 25, Pages 7779-7784
Publisher
Proceedings of the National Academy of Sciences
Online
2015-06-11
DOI
10.1073/pnas.1505629112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
- (2014) J. E. Zuckerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential
- (2013) Frédéric Thuaud et al. CHEMISTRY & BIOLOGY
- Prohibitin and its rapidly emerging role as a biomarker of systemic malignancies
- (2013) Shailendra Kapoor HUMAN PATHOLOGY
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug
- (2013) X. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
- (2012) Che-Ming Jack Hu et al. BIOCHEMICAL PHARMACOLOGY
- Analytical Measurement of PEGylated Molecules
- (2012) Tian-Lu Cheng et al. BIOCONJUGATE CHEMISTRY
- In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles?
- (2012) Yuan Zhang et al. MOLECULAR THERAPY
- Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
- (2012) Mar Creixell et al. Nano Today
- Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4
- (2012) Y. Ren et al. Science Translational Medicine
- Recent Advances in Nonviral Vectors for Gene Delivery
- (2011) Xia Guo et al. ACCOUNTS OF CHEMICAL RESEARCH
- Differentially Charged Hollow Core/Shell Lipid-Polymer-Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery
- (2011) Jinjun Shi et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The role and therapeutic potential of prohibitin in disease
- (2011) Arianne L. Theiss et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
- (2010) Katrin Knop et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestines
- (2010) D. Scott Wilson et al. NATURE MATERIALS
- Prohibitins Are Required for Cancer Cell Proliferation and Adhesion
- (2010) Claudia Sievers et al. PLoS One
- Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells
- (2010) N. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipid-like materials for low-dose, in vivo gene silencing
- (2010) K. T. Love et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
- (2009) Mark E. Davis MOLECULAR PHARMACEUTICS
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA
- (2009) Kim A. Woodrow et al. NATURE MATERIALS
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation
- (2008) Marjorie Robbins et al. HUMAN GENE THERAPY
- Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis
- (2008) Rosalind C. Gregory-Bass et al. INTERNATIONAL JOURNAL OF CANCER
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
- (2008) Frank Alexis et al. MOLECULAR PHARMACEUTICS
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
- (2008) S. Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now